As of January 2026, Neuralink has successfully advanced its "Telepathy" implant program to 21 human participants, enabling individuals with paralysis to control computers and digital devices through thought alone. The company’s current priority is the rollout of a next-generation chip with significantly higher processing power. Additionally, Neuralink is preparing to launch human trials for "Blindsight," a groundbreaking project designed to restore vision by directly stimulating the visual cortex, potentially helping even those who have been blind since birth.
Comments